Drug Type Universal CAR-T |
Synonyms anti-AIDT-1 CAR T-cell therapy (Kiromic Biopharma) |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | US | - | |
Follicular Lymphoma | Preclinical | US | - | |
Mediastinal large B-cell lymphoma | Preclinical | US | - |